Hvidovre based August Faller A/S announces that its parent company, Germany based pharmaceutical packaging specialist August Faller GmbH & Co. KG and Toronto, Canada based Bellwyck Pharma Services have agreed to form a joint venture. Bellwyck and Faller each hold 50 percent of the shares in the new Bellwyck Faller Pharmaceutical Services GmbH, located in Grossbeeren, Brandenburg, Germany. Beginning in early 2018, in addition to the existing contract packaging services, the joint venture will offer packaging and logistics services for clinical trials in the European markets.
Headquartered in Toronto, Canada, Bellwyck Pharma Services, a division of Bellwyck Packaging Inc., is an established provider of Clinical and Commercial Packaging Solutions in Canada and the US, and is now expanding its offering for the European and global market in collaboration with Faller.
The Bellwyck-Faller joint venture’s portfolio for clinical trial management includes storage and distribution capabilities in both ambient and refrigerated temperatures, the management of returns and reconciliation, as well as expiry extension labelling.
With support from Bellwyck Pharma Services in North America, Bellwyck Faller Pharmaceutical Services GmbH can also offer full project management and logistics consultation for clinical trials in the North American market, from pure material distribution to dynamic randomized distribution via IVRS systems; the handling of studies in single or multi-language versions, country-specific packaging including use information/booklets through to consistent temperature control of the supply chain of the study material. The service offering in Bellwyck-Faller’s Grossbeeren site will expand to these offerings for the European and global market as well. The good manufacturing practices laid down for the pharmaceutical industry are ensured for the entire supply chain for contract packaging and clinical trial logistics.
The managing director of Bellwyck Faller Pharmaceutical Services GmbH, Juergen Hendricks, states: “With our new partner company, we want to sustainably establish ourselves among our customers in Europe as a partner with tailored solutions for everything related to the logistics and packaging services which are necessary to optimally organize clinical trials.”
Jeff Sziklai, CEO of Bellwyck Packaging Inc., is excited by the opportunities this joint venture presents: “With the experience and outstanding know-how of our German and Canadian staff, we can now further support the global study requirements of our customers worldwide.”
Dr. Daniel Keesman, CEO of August Faller GmbH & Co. KG, emphasizes: “At the Grossbeeren location, our customers can now also receive logistics and packaging services for clinical trials specifically tailored to their requirements. Our expertise in packaging logistics is optimally complemented by the competence and experience of our Canadian partner.”
Length of text: approx. 3.157 characters (with blank spaces) / approx. 449 words
Further information available at: www.august-faller.com